Maltodextrin

What this is

Maltodextrin is usually treated as a conventional food ingredient or GRAS-affirmed additive-like ingredient rather than a high-concern chemical additive. In the U.S., FDA regulation allows maltodextrin in food with no limitation other than current good manufacturing practice, while FDA's ingredient database lists uses including anticaking/free-flow agent, flavoring adjuvant, humectant, nutritive sweetener, solvent/vehicle, stabilizer/thickener, surface-active agent, and texturizer. The main health question is not classic genotoxicity or cancer toxicity, but whether frequent use as a rapidly digestible refined carbohydrate meaningfully contributes to glycemic load, ultra-processed food exposure, or gut effects. A 2025 citizen petition asks FDA to revoke GRAS treatment for processed refined carbohydrates including maltodextrin, but no enacted ban or revocation was found in the reviewed policy sources.

Safety Review

The critical endpoints experts review in safety assessments. This is not a prediction of harm.

Maltodextrin is best framed as a rapidly digestible refined carbohydrate rather than a classic genotoxin. A human crossover trial showed digestible maltodextrin can produce substantially higher glucose and insulin responses than resistant maltodextrin, and animal/human-review literature reports microbiome, mucus-barrier, and antimicrobial-defense signals of uncertain relevance to ordinary label exposures.